Last reviewed · How we verify
follicle stimulating hormone
follicle stimulating hormone is a Gonadotropin [EPC] Small molecule drug developed by Medical University of Vienna. It is currently FDA-approved for Hormone imbalance symptoms. Also known as: buserelin, r-hFSH, r-hLH, buserelin, r-hFSH, HCG, Bravelle, Follistim.
At a glance
| Generic name | follicle stimulating hormone |
|---|---|
| Also known as | buserelin, r-hFSH, r-hLH, buserelin, r-hFSH, HCG, Bravelle, Follistim, Gonal-F |
| Sponsor | Medical University of Vienna |
| Drug class | Gonadotropin [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
- Hormone imbalance symptoms
Common side effects
Key clinical trials
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study) (NA)
- BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)
- An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin (PHASE1)
- Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (NA)
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) (PHASE3)
- Plasma Relaxin Measurement Based on Endometrial Preparation for Embryo Transfer
- Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring (PHASE1, PHASE2)
- Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- follicle stimulating hormone CI brief — competitive landscape report
- follicle stimulating hormone updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI
Frequently asked questions about follicle stimulating hormone
What is follicle stimulating hormone?
follicle stimulating hormone is a Gonadotropin [EPC] drug developed by Medical University of Vienna, indicated for Hormone imbalance symptoms.
What is follicle stimulating hormone used for?
follicle stimulating hormone is indicated for Hormone imbalance symptoms.
Who makes follicle stimulating hormone?
follicle stimulating hormone is developed and marketed by Medical University of Vienna (see full Medical University of Vienna pipeline at /company/medical-university-of-vienna).
Is follicle stimulating hormone also known as anything else?
follicle stimulating hormone is also known as buserelin, r-hFSH, r-hLH, buserelin, r-hFSH, HCG, Bravelle, Follistim, Gonal-F.
What drug class is follicle stimulating hormone in?
follicle stimulating hormone belongs to the Gonadotropin [EPC] class. See all Gonadotropin [EPC] drugs at /class/gonadotropin-epc.
What development phase is follicle stimulating hormone in?
follicle stimulating hormone is FDA-approved (marketed).
Related
- Drug class: All Gonadotropin [EPC] drugs
- Manufacturer: Medical University of Vienna — full pipeline
- Indication: Drugs for Hormone imbalance symptoms
- Also known as: buserelin, r-hFSH, r-hLH, buserelin, r-hFSH, HCG, Bravelle, Follistim, Gonal-F
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing